MedPath

Alveolar Ridge Augmentation With Curcumin Combined With Xenograft

Phase 4
Not yet recruiting
Conditions
Horizontal Alveolar Bone Loss
Interventions
Registration Number
NCT04971382
Lead Sponsor
Ain Shams University
Brief Summary

A study was performed to investigate the effect of curcumin on the osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) and its underlying potential mechanism. The Results was that Curcumin at an appropriate concentration had no cytotoxicity and could promote osteogenic differentiation of the hPDLSCs

Detailed Description

Patients will be selected from the outpatient clinic of Oral Medicine, Periodontology and Oral diagnosis Department, Faculty of Dentistry, Ain Shams University. The purpose of the study will be explained to all patients and an informed consent will be signed before the conduction of the study .The faculty research ethics committee will review the proposal.

The study will be conducted in the form of Patient Intervention Comparative Outcome (PICO) question (Patient "P", Intervention "I", Comparative "C", Outcome "O"). (Stone 2002) "P": Patient in the study will have enough alveolar ridge height ,suffering from missing from 1 to 3 upper maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual (BL) width that interfere with conventional straight forward implant placement. The minimum BL width included in the study will be 4 mm. "I": Ridge splitting with interposition grafting with curcumin and particulate xenograft grafting. "C":Alveolar ridge splitting with interposition grafting with use of particulate xenograft alone without curcumin . "O":Clinical and radiographic outcome.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Male and female with age range 25-45 years.
  • Patient with enough alveolar ridge height, suffering from missing single or multiple maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual (BL) width that interfere with conventional straight forward implant placement. The minimum BL width included in the study will be 4-5 mm to facilitate ridge splitting and expansion.
  • Systemically free from any diseases as evidenced by Burket's oral medicine health history questionnaire.
  • Patient available during follow up periods.
Exclusion Criteria
  • Smokers.
  • Pregnant and breast feeding females.
  • Patient unwilling to comply to oral hygienic instructions.
  • Patients under any medication or medical condition that affect the bone quality.
  • Vulnerable groups. (e.g decisions impaired individual).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
curcumin combined with particulate xenograft.CurcuminCurcumin will be used in combination with xenograft after ridge splitting surgery Curcumin is widely used in medicine due to medicinal properties, cost-effectiveness, and simple extraction from a turmeric plant that grows in different regions in the world. Recent evidences have shown that curcumin possesses multiple biological activities and pharmacological properties including anti-inflammation , antioxidation , anticancer , antimicrobial , and free radical scavenger effects
alveolar ridge splitting with use of particulate xenograft alone.Curcuminxenograft will be used alone after ridge splitting
Primary Outcome Measures
NameTimeMethod
clinical outcomechange from baseline at 6 months

Assessment the gain in alveolar ridge buccolingual width

Secondary Outcome Measures
NameTimeMethod
stability"through study completion, an average of 1 year

Assessment of the primary implant stability Quotient in the regenerated bone

Trial Locations

Locations (1)

faculty of dentistry Ain shams university

🇪🇬

Cairo, Egypt

faculty of dentistry Ain shams university
🇪🇬Cairo, Egypt
hala abuelela, professor
Contact
01002500182
dr.halaabuelela@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.